377 related articles for article (PubMed ID: 32443566)
1. Metformin: Sentinel of the Epigenetic Landscapes That Underlie Cell Fate and Identity.
Menendez JA
Biomolecules; 2020 May; 10(5):. PubMed ID: 32443566
[TBL] [Abstract][Full Text] [Related]
2. Benefits of Metformin in Attenuating the Hallmarks of Aging.
Kulkarni AS; Gubbi S; Barzilai N
Cell Metab; 2020 Jul; 32(1):15-30. PubMed ID: 32333835
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic effects of metformin: From molecular mechanisms to clinical implications.
Bridgeman SC; Ellison GC; Melton PE; Newsholme P; Mamotte CDS
Diabetes Obes Metab; 2018 Jul; 20(7):1553-1562. PubMed ID: 29457866
[TBL] [Abstract][Full Text] [Related]
4. Metformin regulates global DNA methylation via mitochondrial one-carbon metabolism.
Cuyàs E; Fernández-Arroyo S; Verdura S; García RÁ; Stursa J; Werner L; Blanco-González E; Montes-Bayón M; Joven J; Viollet B; Neuzil J; Menendez JA
Oncogene; 2018 Feb; 37(7):963-970. PubMed ID: 29059169
[TBL] [Abstract][Full Text] [Related]
5. Metformin targets histone acetylation in cancer-prone epithelial cells.
Cuyàs E; Fernández-Arroyo S; Joven J; Menendez JA
Cell Cycle; 2016 Dec; 15(24):3355-3361. PubMed ID: 27792453
[TBL] [Abstract][Full Text] [Related]
6. Metformin: Targeting the Metabolo-Epigenetic Link in Cancer Biology.
Cuyàs E; Verdura S; Martin-Castillo B; Menendez JA
Front Oncol; 2020; 10():620641. PubMed ID: 33604300
[TBL] [Abstract][Full Text] [Related]
7. Cellular stress and AMPK activation as a common mechanism of action linking the effects of metformin and diverse compounds that alleviate accelerated aging defects in Hutchinson-Gilford progeria syndrome.
Finley J
Med Hypotheses; 2018 Sep; 118():151-162. PubMed ID: 30037605
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic regulation of cell fate reprogramming in aging and disease: A predictive computational model.
Folguera-Blasco N; Cuyàs E; Menéndez JA; Alarcón T
PLoS Comput Biol; 2018 Mar; 14(3):e1006052. PubMed ID: 29543808
[TBL] [Abstract][Full Text] [Related]
9. Epigenetics recording varied environment and complex cell events represents the origin of cellular aging.
Guo XJ; Yang D; Zhang XY
J Zhejiang Univ Sci B; 2019 Jul; 20(7):550-562. PubMed ID: 31168969
[TBL] [Abstract][Full Text] [Related]
10. Metformin and Aging: A Review.
Glossmann HH; Lutz OMD
Gerontology; 2019; 65(6):581-590. PubMed ID: 31522175
[TBL] [Abstract][Full Text] [Related]
11. Loss of epigenetic information as a cause of mammalian aging.
Yang JH; Hayano M; Griffin PT; Amorim JA; Bonkowski MS; Apostolides JK; Salfati EL; Blanchette M; Munding EM; Bhakta M; Chew YC; Guo W; Yang X; Maybury-Lewis S; Tian X; Ross JM; Coppotelli G; Meer MV; Rogers-Hammond R; Vera DL; Lu YR; Pippin JW; Creswell ML; Dou Z; Xu C; Mitchell SJ; Das A; O'Connell BL; Thakur S; Kane AE; Su Q; Mohri Y; Nishimura EK; Schaevitz L; Garg N; Balta AM; Rego MA; Gregory-Ksander M; Jakobs TC; Zhong L; Wakimoto H; El Andari J; Grimm D; Mostoslavsky R; Wagers AJ; Tsubota K; Bonasera SJ; Palmeira CM; Seidman JG; Seidman CE; Wolf NS; Kreiling JA; Sedivy JM; Murphy GF; Green RE; Garcia BA; Berger SL; Oberdoerffer P; Shankland SJ; Gladyshev VN; Ksander BR; Pfenning AR; Rajman LA; Sinclair DA
Cell; 2023 Jan; 186(2):305-326.e27. PubMed ID: 36638792
[TBL] [Abstract][Full Text] [Related]
12. Metformin mediated reversal of epithelial to mesenchymal transition is triggered by epigenetic changes in E-cadherin promoter.
Banerjee P; Surendran H; Chowdhury DR; Prabhakar K; Pal R
J Mol Med (Berl); 2016 Dec; 94(12):1397-1409. PubMed ID: 27534967
[TBL] [Abstract][Full Text] [Related]
13. Metformin alleviates ageing cellular phenotypes in Hutchinson-Gilford progeria syndrome dermal fibroblasts.
Park SK; Shin OS
Exp Dermatol; 2017 Oct; 26(10):889-895. PubMed ID: 28192606
[TBL] [Abstract][Full Text] [Related]
14. Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT): from cancer stem cells to aging-associated fibrosis.
Cufí S; Vazquez-Martin A; Oliveras-Ferraros C; Martin-Castillo B; Joven J; Menendez JA
Cell Cycle; 2010 Nov; 9(22):4461-8. PubMed ID: 21088486
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumor activity of metformin: from metabolic and epigenetic perspectives.
Yu X; Mao W; Zhai Y; Tong C; Liu M; Ma L; Yu X; Li S
Oncotarget; 2017 Jan; 8(3):5619-5628. PubMed ID: 27902459
[TBL] [Abstract][Full Text] [Related]
16. Insulin-Like Growth Factor 1/Mammalian Target of Rapamycin and AMP-Activated Protein Kinase Signaling Involved in the Effects of Metformin in the Human Endometrial Cancer.
Cai D; Sun H; Qi Y; Zhao X; Feng M; Wu X
Int J Gynecol Cancer; 2016 Nov; 26(9):1667-1672. PubMed ID: 27654259
[TBL] [Abstract][Full Text] [Related]
17. Anti-Aging Effect of Metformin: A Molecular and Therapeutical Perspective.
Torres W; Nava M; Galbán N; Gómez Y; Morillo V; Rojas M; Cano C; Chacín M; D Marco L; Herazo Y; Velasco M; Bermúdez V; Rojas-Quintero J
Curr Pharm Des; 2020; 26(35):4496-4508. PubMed ID: 32674728
[TBL] [Abstract][Full Text] [Related]
18. Metformin-mediated epigenetic modifications in diabetes and associated conditions: Biological and clinical relevance.
Giordo R; Posadino AM; Mangoni AA; Pintus G
Biochem Pharmacol; 2023 Sep; 215():115732. PubMed ID: 37541452
[TBL] [Abstract][Full Text] [Related]
19. Molecular targets of metformin antitumor action.
Sośnicki S; Kapral M; Węglarz L
Pharmacol Rep; 2016 Oct; 68(5):918-25. PubMed ID: 27362768
[TBL] [Abstract][Full Text] [Related]
20. Sirt1 and Parp1 as epigenome safeguards and microRNAs as SASP-associated signals, in cellular senescence and aging.
Hekmatimoghaddam S; Dehghani Firoozabadi A; Zare-Khormizi MR; Pourrajab F
Ageing Res Rev; 2017 Nov; 40():120-141. PubMed ID: 28993289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
